GLAXO SMITH KLINE DATA LINKS PAXIL TO INCREASED RISK OF BIRTH DEFECTS

Jeremy Thurman
Attorney
(866) 735-1102 Ext 412
Posted by Jeremy ThurmanMay 03, 2007 9:03 AM

On December 13, 2005, Glaxo Smith Kline released a follow up to a prior study comparing the effects of bupropion to other antidepressants. The preliminary study and it follow up are available on the GSK website [insert link to study]. Though not specifically powered to study the effects of Paxil (paroxetine), GSK concluded "In this study, the use of paroxetine in the first trimester of pregnancy was associated with an increased risk of congenital malformations, and a trend towards an increased risk of cardiovascular malformations, compared with the use of other antidepressants."

If you or a loved one has been injured as a result of Paxil, please contact our firm, we are now reviewing these cases.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Oklahoma City

InjuryBoard Oklahoma City RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Oklahoma City is brought to you by McIntyre Law

Legal Assistance Center

More Info
McIntyre Law (866) 735-1102 Ext 410
google
Personal Injury Lawyers Serving: Oklahoma City, Tulsa, Stillwater, Norman, Bartlesville, Broken Arrow, Duncan, Edmond, Enid, Lawton, Midwest City, Moore, Muskogee, Ponca City, Shawnee, Ardmore
1300 S. MeridianSuite 501, Oklahoma City, Oklahoma 73108 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address